12 minutes ago By James W Kelly & PA Media, BBC News Getty Images An appeal has been launched for O blood-type donors to book appointments across the...
Kyverna Therapeutics (KYTX) should be on an investor’s radar in 2024, led by bullish analyst sentiments and an innovative product pipeline. Tradingbiz analyst Rahul Nambiampurath mentions...
London businesses registered another rise in output midway through the second quarter of 2024, albeit with the rate of growth losing some momentum. The headline NatWest...